HC Wainwright & Co. Reiterates Buy on Atreca, Maintains $25 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Atreca (NASDAQ:BCEL) with a Buy and maintains $25 price target.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Otonomy (NASDAQ:OTIC) shares increased by 19.1% to $0.21 during Thursday’s pre-market session. The company’s market cap stands…
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Atreca Q2 EPS $(0.72), Same YoY
Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.72) per share. This is unchanged from the same period last year.
IBM And 20 Stocks Moving Premarket
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) rose 32.1% to $1.40 in pre-market trading after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.